https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-03 / Ann. Surg. Oncol. 2008 Aug;15(8):2310-72008-06-03 00:00:002021-11-15 17:04:28Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Cancer Biother. Radiopharm. 2008 Jun;23(3):321-312008-06-01 00:00:002019-02-15 08:35:00Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Int. J. Oncol. 2008 Jun;32(6):1317-242008-06-01 00:00:002019-02-15 08:35:00IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Gan To Kagaku Ryoho 2008 Jun;35(6):926-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Gan To Kagaku Ryoho 2008 Jun;35(6):926-302008-06-01 00:00:002019-02-15 08:59:42[Immunotherapy for glioma]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / J. Immunother. 2008 Jun;31(5):458-65
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / J. Immunother. 2008 Jun;31(5):458-652008-06-01 00:00:002019-02-15 09:19:27Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-06-01 / Curr Opin Investig Drugs 2008 Jun;9(6):565-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-06-01 / Curr Opin Investig Drugs 2008 Jun;9(6):565-92008-06-01 00:00:002019-02-15 09:23:42Immunotherapy of pancreatic carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-29 / Int. J. Radiat. Oncol. Biol. Phys. 2009 Jan;73(1):128-352008-05-29 00:00:002019-02-15 08:34:59Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-20 / Vaccine 2008 Jul;26(29-30):3735-41
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-20 / Vaccine 2008 Jul;26(29-30):3735-412008-05-20 00:00:002019-02-15 09:15:04Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-17 / Cancer Immunol. Immunother. 2009 Jan;58(1):61-92008-05-17 00:00:002021-11-15 17:04:52Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-05-15 / Gene Ther. 2008 Oct;15(19):1321-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-05-15 / Gene Ther. 2008 Oct;15(19):1321-92008-05-15 00:00:002019-02-15 09:19:21Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency
